Redeye hosts its first Regenerative Medicine / Cell Therapy event. Interesting companies in different areas within the theme will present.

 

The event will begin with an introduction led by Redeye’s Equity Analyst Richard Ramanius. This is a unique opportunity for investors interested in this space to learn more, hopefully generating new investment ideas.

 

The participating companies will share their equity story, project status, and triggers ahead,

 

Following the presentations, Redeye’s analysts will hold Q&A sessions where questions are open for the audience.

 

NOTE!
Companies and schedules may change before the event starts.
You can save the date in your calendar by using Add to calendar.